Cytometric assessment of cytostatic and cytotoxic effects of topical glaucoma medications on human epithelial corneal line cells

Cytometry Part B - Clinical Cytometry

Volumn 78, Issue 2, 2010, Pages 130-137

  Pozarowska, Dorota ^a   Pozarowski, Piotr ^a   Darzynkiewicz, Zbigniew ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Antiglaucoma topical medications; Apoptosis; Cell cycle; Cell death; Cell proliferation

Indexed keywords

ANTIGLAUCOMA AGENT; BROXURIDINE; CASPASE 3;

APOPTOSIS; ARTICLE; CELL COUNT; CELL DEATH; CELL DENSITY; CELL LINE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CORNEA CELL; CYTOSTASIS; CYTOTOXICITY; ENZYME ACTIVATION; EPITHELIUM CELL; GLAUCOMA; GROWTH CURVE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LASER SCANNING CYTOMETRY; PRIORITY JOURNAL;

ADMINISTRATION, TOPICAL; ANTIHYPERTENSIVE AGENTS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; EPITHELIUM, CORNEAL; GLAUCOMA; HUMANS; LASER SCANNING CYTOMETRY; SENSITIVITY AND SPECIFICITY; TOXICITY TESTS;

EID: 77749301896     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20493     Document Type: Article

References (28)

1. Cheong H, Johnson J, Cormier M, Hosseini K. In vitro cytotoxicity of eight β-blockers in human corneal epithelial and retinal pigment epithelial cell lines: Comparison with epidermal keratinocytes and dermal fibroblasts. Toxicol In Vitro 2008;22:1070-1076.
2. Markstein R. Physiological aspects in the transfer of topical drugs into, within, and out of the eye. In: Orgül S, Flammer J, editors. Pharmacotherapy in Glaucoma. Bern: Verlag Hans Huber; 2000. pp 55-63.
3. Okada Y. Effect of topical antiglaucoma medictions on corneal epithelium as evaluation by gene expression patterns. Cornea 2007;26 (Suppl 1):S46-S54.
4. Noecker RJ, Herrygers LA, Anwaruddin R. Cornea and conjunctival changes caused by commonly used glaucoma medication. Cornea 2004;23:490-496.
5. Inoue K, Okugawa K, Oshika T, Amano S. Influence of dorzolamide on corneal endotherium. Jpn J Ophthalmol 2003;47:129-133.
6. Harasymowycz P, Papamatheakis D, Ennis M, Brady M, Gordon K. Relation between travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma. Cornea 2007;26:34-41.
7. Fraunfelder FW. Corneal toxicity from topical ocular and systemic medication. Cornea 2006;25:1133-1138.
8. Yee RW, Norcom EG, Zhao XC. Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human corneal epithelial cell culture system. Adv Ther 2006;23:511-519.
9. Pozarowski P, Huang X, Gong RW, Priebe W, Darzynkiewicz Z. Simple, semi-automatic assay of cytostatic and cytotoxic effects of antitumor drugs by laser-scanning cytometry (LSC): Effects of the bisintercalator WP631 on growth and cell cycle of T-24 cells. Cytometry Part A 2004;57A:113-119.
10. Pozarowski P, Grabarek J, Darzynkiewicz Z. Flow cytometry of apoptosis. In: Robinson JP, Darzynkiewicz Z, Dean P, Hibbs A, Orfao A, Rabinovitch P, Wheeless L, editors. Current Protocols In Cytometry. New York: John Wiley and Sons; 2003. pp 1-33.
11. Pozarowski P, Huang X, Halicka D, Lee B, Johnson G, Darzynkiewicz Z. Interaction of fluorochrome-labeled caspase inhibitors with apoptotic cells. A caution In data interpretation. Cytometry Part A 2003;55A:50-60.
12. Pozarowski P, Halicka DH, Darzynkiewicz Z. NF-κB inhibitor sesquiterpene parthenolide induces concurrently atypical apoptosis and necrosis: Difficulties in identification of dead cells in such cultures. Cytometry Part A 2003;54A:118-124.
13. Pozarowski P, Holden E, Darzynkiewicz Z. Laser scanning cytometry: Principles and applications. Methods Mol Biol 2006;319:165-192.
14. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. Cytometry in cell necrobiology. Analysis of apoptosis and accidental cell death (necrosis). Cytometry 1997;27:1-20.
15. Darzynkiewicz Z, Traganos F, Kapuscinski J, Staiano-Coico L, Melamed MR. Accessibility of DNA in situ to various fluorochromes: Relationship to chromatin changes during erythroid differentiation of Friend leukemia cells. Cytometry 1984; 5:355-363.
16. Hamard P, Blondin C, Debbash C, Warnet JM, Baudouin C, Brignole F. In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells. Graefes Arch Clin Exp Ophthalmol 2003;241: 1037-1043.
17. Liang H, Baudouin C, Pauly A, Bringnole-Baudouin F. Conjunctival an corneal reaction in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride. Br J Ophthalmol 2008;92:1275-1282.
18. McCarey B, Edekhaser H. In vivo corneal permeability following treatment with prostaglandin analogs (correction of analogs) with or without benzalonium chloride. J Ocul Pharmacol Ther 2007;23:445-451.
19. Kahook MY, Noecker RJ. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative- free artificial tears. Cornea 2008;27:339-343.
20. De Saint Jean M, Debbasch C, Brignole F, Rat P, Warnet JM, Baudouin C. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. Curr Eye Res 2000;20:85-94.
21. Brasnu E, Brignole-Baudouin F, Riancho L, Warnet JM, Baudouin C. Comparative study on the cytotoxic effect of benzalkonium chloride on the Wong-Kilboure derivative od Chang conjunctival and IOBA-NHC cell lines. Mol Vis 2008;14:394-402.
22. Baudouin C, Riancho L, Warnet JM, Brignole F. In vitro studies of antiglaucomatous prostaglandin analogues: Travoprost with and without benzalkonium chloride and preserved latanoprost. Invest Ophthalmol Vis Sci 2007;48:4123-4128.
23. Yee RW. The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: A review. Curr Opin Ophthalmol 2007;18:134-139.
24. Wu KY, Wang HZ, Hong SJ. Effects of antiglaucoma drugs on cellular proliferation in cultured human corneal keratocytes. Kaohsiung J Med Sci 2006;22:120-125.
25. Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatprost in conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci 2005;46:244-2450.
26. Wu KY, Wang HZ, Hong SJ. Cellular cytotoxicity of antiglaucoma drugs in cultured corneal endothelium cells. Kaohsiung J Med Sci 2007;23:105-111.
27. Guenoun J-M, Baudouin C, Rat P, Pauly A, Warnet J-M, Brignole-Baudouin F. In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatopros on conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci 2005;46:4594-4599.
28. Pisella PJ, Debbasch C, Hamard P, Creuzot-Garcher C, Rat P, Brignole F, Baudouin C. Conjunctival proinflammatory and proapoptotic effect of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci 2004;45:1360-1368.